Owen C A, Campbell M A, Sannes P L, Boukedes S S, Campbell E J
Department of Medicine, University of Utah Health Sciences Center, Salt Lake City 84132, USA.
J Cell Biol. 1995 Nov;131(3):775-89. doi: 10.1083/jcb.131.3.775.
Serine proteinases of human polymorphonuclear neutrophils play an important role in neutrophil-mediated proteolytic events; however, the non-oxidative mechanisms by which the cells can degrade extracellular matrix in the presence of proteinase inhibitors have not been elucidated. Herein, we provide the first report that human neutrophils express persistently active cell surface-bound human leukocyte elastase and cathepsin G on their cell surface. Unstimulated neutrophils have minimal cell surface expression of these enzymes; however, phorbol ester induces a 30-fold increase. While exposure of neutrophils to chemoattractants (fMLP and C5a) stimulates modest (two- to threefold) increases in cell surface expression of serine proteinases, priming with concentrations of lipopolysaccharide as low as 100 fg/ml leads to striking (up to 10-fold) increase in chemoattractant-induced cell surface expression, even in the presence of serum proteins. LPS-primed and fMLP-stimulated neutrophils have approximately 100 ng of cell surface human leukocyte elastase activity per 10(6) cells. Cell surface-bound human leukocyte elastase is catalytically active, yet is remarkably resistant to inhibition by naturally occurring proteinase inhibitors. These data indicate that binding of serine proteinases to the cell surface focuses and preserves their catalytic activity, even in the presence of proteinase inhibitors. Upregulated expression of persistently active cell surface-bound serine proteinases on activated neutrophils provides a novel mechanism to facilitate their egress from the vasculature, penetration of tissue barriers, and recruitment into sites of inflammation. Dysregulation of the cell surface expression of these enzymes has the potential to cause tissue destruction during inflammation.
人类多形核中性粒细胞的丝氨酸蛋白酶在中性粒细胞介导的蛋白水解事件中起重要作用;然而,在存在蛋白酶抑制剂的情况下,细胞降解细胞外基质的非氧化机制尚未阐明。在此,我们首次报道人类中性粒细胞在其细胞表面持续表达活性的细胞表面结合型人类白细胞弹性蛋白酶和组织蛋白酶G。未受刺激的中性粒细胞这些酶的细胞表面表达极少;然而,佛波酯可使其增加30倍。虽然中性粒细胞暴露于趋化因子(fMLP和C5a)会刺激丝氨酸蛋白酶的细胞表面表达适度增加(两到三倍),但用低至100 fg/ml的脂多糖浓度进行预处理会导致趋化因子诱导的细胞表面表达显著增加(高达10倍),即使在存在血清蛋白的情况下也是如此。经脂多糖预处理并受fMLP刺激的中性粒细胞每10(6)个细胞约有100 ng的细胞表面人类白细胞弹性蛋白酶活性。细胞表面结合型人类白细胞弹性蛋白酶具有催化活性,但对天然存在的蛋白酶抑制剂的抑制作用具有显著抗性。这些数据表明,即使在存在蛋白酶抑制剂的情况下,丝氨酸蛋白酶与细胞表面的结合也会集中并保留其催化活性。活化的中性粒细胞上持续活性的细胞表面结合型丝氨酸蛋白酶的上调表达提供了一种新机制,以促进它们从脉管系统逸出、穿透组织屏障并募集到炎症部位。这些酶的细胞表面表达失调有可能在炎症期间导致组织破坏。